Blank Cover Image

Membrane-bound form of monocyte chemoattractant protein-1 enhances antitumor effects of suicide gene therapy in a model of hepatocellular carcinoma

フォーマット:
論文
責任表示:
Marukawa, Yohei ; Nakamoto, Yasunari ; Kakinoki, Kaheita ; Tsuchiyama, Tomoya ; Iida, Noriho ; Kagaya, Takashi ; Sakai, Yoshio ; Naito, Makoto ; Mukaida, Naofumi ; Kaneko, Shuichi
言語:
英語
出版情報:
Nature Publishing Group, 2012-05-01
著者名:
Marukawa, Yohei
Nakamoto, Yasunari
Kakinoki, Kaheita
Tsuchiyama, Tomoya
Iida, Noriho
Kagaya, Takashi
Sakai, Yoshio
Naito, Makoto
Mukaida, Naofumi
Kaneko, Shuichi
続きを見る
掲載情報:
Cancer Gene Therapy
ISSN:
0929-1903  CiNii Research  Webcat Plus  JAIRO
巻:
19
通号:
5
開始ページ:
312
終了ページ:
319
バージョン:
author
概要:
Suicide gene therapy using the herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV) system combined with monocyte chemoattractant protein-1 (MCP-1) provides significant antitumor efficacy. The current study was designed to evaluate the antitumor immunity of a newly developed membrane-bound form of MCP-1 (mMCP-1) in an immunocompetent mouse model of hepatocellular carcinoma (HCC). A recombinant adenovirus vector (rAd) harboring the human MCP-1 gene and the membrane-spanning domain of the CX3CL1 gene was used. Large amounts of MCP-1 protein were expressed and accumulated on the tumor cell surface. The growth of subcutaneous tumors was markedly suppressed when tumors were treated with mMCP-1, as compared with soluble MCP-1, in combination with the HSV-tk/GCV system (P<0.01). The numbers of Mac-1-, CD4- and CD8a-positive cells were significantly higher in tumor tissues (P<0.05), and tumor necrosis factor (TNF) mRNA expression levels with mMCP-1 were almost five-fold higher than those with soluble MCP-1. These results indicate that the delivery of the mMCP-1 gene greatly enhanced antitumor effects following the apoptotic stimuli by promoting the recruitment and activation of macrophages and T lymphocytes, suggesting a novel strategy of immune-based gene therapy in the treatment of patients with HCC.Cancer Gene Therapy advance online publication, 9 March 2012; doi:10.1038/cgt.2012.3. 続きを見る
URL:
http://hdl.handle.net/2297/30373
タイトル・著者・出版者が同じ資料

類似資料:

1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 

Marukawa, Yohei, Nakamoto, Yasunari, Kakinoki, Kaheita, Tsuchiyama, Tomoya, Iida, Noriho, Kagaya, Takashi, Sakai, &hellip;

Nature Publishing Group

Iida, Noriho, Nakamoto, Yasunari, Baba, Tomohisa, Kakinoki, Kaheita, Li, Ying-Yi, Wu, Yu, Matsushita, Kouji, Kaneko, &hellip;

Oxford University Press

Tsuchiyama, Tomoya, Nakamoto, Yasunari, Sakai, Yoshio, Mukaida, Naofumi, Kaneko, Shuichi

Japanese Cancer Association / Blackwell Publishing Ltd

Takata, Yoshiko, Nakamoto, Yasunari, Nakada, Akiko, Terashima, Takeshi, Arihara, Fumitaka, Kitahara, Masaaki, Kakinoki, &hellip;

Elsevier

Kakinoki, Kaheita, Nakamoto, Yasunari, Kagaya, Takashi, Tsuchiyama, Tomoya, Sakai, Yoshio, Nakahama, Tohru, Mukaida, &hellip;

Wiley-Blackwell

Nakagawa, Hidetoshi, Mizukoshi, Eishiro, Iida, Noriho, Terashima, Takeshi, Kitahara, Masaaki, Marukawa, Yohei, Kitamura, &hellip;

Springer-Verlag

Tsuchiyama, T., Nakamoto, Yasunari, Sakai, Y., Mukaida, Naofumi, Sawabu, Norio, Kaneko, Shuichi

金沢大学がん研究所

Kitahara, Masaaki, Mizukoshi, Eishiro, Nakamoto, Yasunari, Mukaida, Naofumi, Matsushima, Kouji, Kaneko, Shuichi

Elsevier

Nakamoto, Yasunari, Mizukoshi, Eishiro, Kitahara, Masaaki, Arihara, Fumitaka, Sakai, Yoshio, Kakinoki, Kaheita, Fujita, &hellip;

Blackwell Publishing

Fujii, Chifumi, Nakamoto, Yasunari, Lu, Peirong, Tsuneyama, Koichi, Popivanova, Boryana K., Kaneko, Shuichi, Mukaida, &hellip;

Wiley-Liss

Iida, Noriho, Nakamoto, Yasunari, Baba, Tomohisa, Nakagawa, Hidetoshi, Mizukoshi, Eishiro, Naito, Makoto, Mukaida, &hellip;

American Association for Cancer Research